Study to Evaluate the Non-inferiority of Cavir in HBeAg(+)Chronic Hepatitis B Patients Treated With Baraclude
- Status
- UNKNOWN
- Phase
- PHASE4
Clinical Trials Related to Chronic Hepatitis B
Related studies linked through entity extraction aliases.
Efficacy of HBV Vaccine in Consolidation of Nucleos(t)Ide Analogues Therapy
- Status
- COMPLETED
- Phase
- PHASE4
FibroTouch Non-invasive Evaluation of Liver Fibrosis and Cirrhosis
- Status
- COMPLETED
- Phase
- N/A
Combined Therapy With Peginterferon Alfa-2a With NA in NA-treated HBeAg Positive Patients
- Status
- UNKNOWN
- Phase
- PHASE4
Roll-over After 3-year Trial for Tenofovir in Mild Chronic Hepatitis B
- Status
- UNKNOWN
- Phase
- PHASE4
Study of ARC-520 in Participants With Hepatitis B Virus e Antigen (HBeAg) Positive Chronic Hepatitis B Virus
- Status
- TERMINATED
- Phase
- PHASE2
Safety and Tolerability of TG1050: A Dose-finding Study
- Status
- COMPLETED
- Phase
- PHASE1
Sustained Viral Response in Chronic Hepatitis B Patients Who Achieved HBeAg Seroncongversion After Interferon Therapy
- Status
- UNKNOWN
- Phase
- N/A
Dose-Ranging Study to Assess the Safety, PK and Initial Antiviral Efficacy of NVR 3-778 in Chronic HBV Patients
- Status
- COMPLETED
- Phase
- PHASE1
Efficay of Extended Peginterferon Alpha 2a Treatment in HBeAg Negative Chronic Hepatitis B Patients
- Status
- UNKNOWN
- Phase
- N/A
Efficacy of Extended Peginterferon Alpha 2a Treatment in HBeAg Positive Chronic Hepatitis B Patients
- Status
- COMPLETED
- Phase
- N/A
Efficacies of Entecavir Add on HBeAg Positive Patients With HBV DNA Positive During Peginterferon Alpha 2a Treatment
- Status
- UNKNOWN
- Phase
- PHASE4
Efficacies of Entecavir Add on HBeAg Negative Patients With HBV DNA Positive During Peginterferon Alpha 2a Treatment
- Status
- UNKNOWN
- Phase
- PHASE4
Add-on Peginterferon Following Nucleos(t)Ide Analogue Treatment
- Status
- COMPLETED
- Phase
- PHASE2
Efficacy of Peginterferon Alpha 2a Therapy in Chronic Hepatitis B Patients Being Treated With Nucleoside(Acid) Analogues
- Status
- UNKNOWN
- Phase
- PHASE4
Non-investigational Study to Evaluate Adenovirus Serotype 5 (Ad5) Neutralizing Antibodies (nAb) in Patients With Chronic Hepatitis B Virus (HBV) Mono-infection
- Status
- COMPLETED
- Phase
- NA
Study of ARC-520 in Patient With Chronic Hepatitis B Virus
- Status
- WITHDRAWN
- Phase
- PHASE2
Sustained Viral Response in Patients Achieved HBsAg Level≤100 IU/ml After Completed Interferon Treatment
- Status
- UNKNOWN
- Phase
- N/A
Lamivudine Extending Therapy in Chronic Hepatitis B Patients After 3-year of Oral Antiviral Agents
- Status
- UNKNOWN
- Phase
- PHASE4
Sustained HBsAg and Viral Response in Patients Achieved HBsAg Loss by Interferon Treatment
- Status
- UNKNOWN
- Phase
- N/A